These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 37055446)

  • 1. Dichotomous versus 5-scale grading system for the interpretation of the point-of-care immunoassay for tear matrix metalloproteinase-9 in dry eye.
    Oh JY; Chun YS; Kim KW
    Sci Rep; 2023 Apr; 13(1):6085. PubMed ID: 37055446
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Matrix Metalloproteinase 9 Testing in Dry Eye Disease Using a Commercially Available Point-of-Care Immunoassay.
    Messmer EM; von Lindenfels V; Garbe A; Kampik A
    Ophthalmology; 2016 Nov; 123(11):2300-2308. PubMed ID: 27665213
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Correlation of Tear Film Osmolarity and 2 Different MMP-9 Tests With Common Dry Eye Tests in a Cohort of Non-Dry Eye Patients.
    Schargus M; Ivanova S; Kakkassery V; Dick HB; Joachim S
    Cornea; 2015 Jul; 34(7):739-44. PubMed ID: 25909238
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tear Proteomics Approach to Monitoring Sjögren Syndrome or Dry Eye Disease.
    Kuo MT; Fang PC; Chao TL; Chen A; Lai YH; Huang YT; Tseng CY
    Int J Mol Sci; 2019 Apr; 20(8):. PubMed ID: 31010136
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Importance of tear volume for positivity of tear matrix metalloproteinase-9 immunoassay.
    Jun JH; Lee YH; Son MJ; Kim H
    PLoS One; 2020; 15(7):e0235408. PubMed ID: 32649686
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tear Osmolarity and Matrix Metallopeptidase-9 in Dry Eye Associated with Sjögren's Syndrome.
    Kook KY; Jin R; Li L; Yoon HJ; Yoon KC
    Korean J Ophthalmol; 2020 Jun; 34(3):179-186. PubMed ID: 32495525
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparative Evaluation of Matrix Metalloproteinase-9 Immunoassay and Tear Osmolarity Measurement for Diagnosing Severity of Dry Eye Disease.
    Choi M; Park YM; Ko BY
    Korean J Ophthalmol; 2023 Oct; 37(5):409-416. PubMed ID: 37621090
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Estimating basal tear osmolarity in normal and dry eye subjects.
    Willshire C; Buckley RJ; Bron AJ
    Cont Lens Anterior Eye; 2018 Feb; 41(1):34-46. PubMed ID: 28958415
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Evaluation of ocular surface status and function in primary Sjögren's syndrome with hypothyroidism].
    Yu HZ; Zeng WZ; Wu WY; Yao ZQ; Feng Y
    Beijing Da Xue Xue Bao Yi Xue Ban; 2022 Aug; 54(4):705-711. PubMed ID: 35950396
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Different perception of dry eye symptoms between patients with and without primary Sjogren's syndrome.
    Kim M; Chun YS; Kim KW
    Sci Rep; 2022 Feb; 12(1):2172. PubMed ID: 35140286
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of point-of-care test for elevated tear matrix metalloproteinase 9 in post-LASIK dry eyes.
    Chan TC; Ye C; Chan KP; Chu KO; Jhanji V
    Br J Ophthalmol; 2016 Sep; 100(9):1188-91. PubMed ID: 26682569
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tear Proteomics Approach to Distinguishing Primary from Secondary Sjögren's Syndrome for Dry Eye Patients with Long-Term Instillation of Eyedrops.
    Hsiao YT; Huang YT; Yu HJ; Fang PC; Kuo MT
    Int J Mol Sci; 2022 Dec; 23(23):. PubMed ID: 36499565
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Novel point-of-care biomarkers of the dry anophthalmic socket syndrome: tear film osmolarity and matrix metalloproteinase 9 immunoassay.
    Rokohl AC; Wall K; Trester M; Wawer Matos PA; Guo Y; Adler W; Pine KR; Heindl LM
    Graefes Arch Clin Exp Ophthalmol; 2023 Mar; 261(3):821-831. PubMed ID: 36357674
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Correlation of Dry Eye Workshop Dry Eye Severity Grading System With Tear Meniscus Measurement by Optical Coherence Tomography and Tear Osmolarity.
    Tukenmez-Dikmen N; Yildiz EH; Imamoglu S; Turan-Vural E; Sevim MS
    Eye Contact Lens; 2016 May; 42(3):153-7. PubMed ID: 26067398
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Reduced tear thrombospondin-1/matrix metalloproteinase-9 ratio can aid in detecting Sjögren's syndrome etiology in patients with dry eye.
    Masli S; Akpek EK
    Clin Transl Sci; 2022 Aug; 15(8):1999-2009. PubMed ID: 35610740
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Short-Term Therapeutic Effects of Topical Corticosteroids on Refractory Dry Eye Disease: Clinical Usefulness of Matrix Metalloproteinase 9 Testing as a Response Prediction Marker.
    Ryu KJ; Kim S; Kim MK; Paik HJ; Kim DH
    Clin Ophthalmol; 2021; 15():759-767. PubMed ID: 33654374
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [A preliminary study on the tear matrix metalloproteinase 9 point-of-care assay using a domestic kit].
    Wan XC; Zhang H; Shen Y; Zhou SY; Yang P; Zhou XJ; Gu H; Le QH; Xu JJ; Zhou XT; Hong JX
    Zhonghua Yan Ke Za Zhi; 2023 Apr; 59(4):272-278. PubMed ID: 37012590
    [No Abstract]   [Full Text] [Related]  

  • 18. Performance of tear osmolarity compared to previous diagnostic tests for dry eye diseases.
    Versura P; Profazio V; Campos EC
    Curr Eye Res; 2010 Jul; 35(7):553-64. PubMed ID: 20597641
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sensitivity and specificity of a point-of-care matrix metalloproteinase 9 immunoassay for diagnosing inflammation related to dry eye.
    Sambursky R; Davitt WF; Latkany R; Tauber S; Starr C; Friedberg M; Dirks MS; McDonald M
    JAMA Ophthalmol; 2013 Jan; 131(1):24-8. PubMed ID: 23307206
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Study design and baseline findings from the progression of ocular findings (PROOF) natural history study of dry eye.
    McDonnell PJ; Pflugfelder SC; Stern ME; Hardten DR; Conway T; Villanueva L; Hollander DA
    BMC Ophthalmol; 2017 Dec; 17(1):265. PubMed ID: 29284427
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.